NCT06855888

Brief Summary

In pancreaticojejunostomy following pancreaticoduodenectomy for soft pancreas, a randomized controlled trial will be conducted to compare a patient group using the conventional Blumgart modified technique and a patient group in which mattress sutures are added to the cranial and caudal sides of the pancreaticojejunostomy after the Blumgart modified technique (three-sided mattress suture technique), and to evaluate the safety and usefulness of the three-sided mattress suture technique by comparing the incidence of pancreatic fistula (ISGPF grade B or C).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
45mo left

Started Dec 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Dec 2024Dec 2029

Study Start

First participant enrolled

December 10, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 21, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 4, 2025

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

March 4, 2025

Status Verified

February 1, 2025

Enrollment Period

5.1 years

First QC Date

February 21, 2025

Last Update Submit

March 3, 2025

Conditions

Keywords

mattress suturepancreaticojejunostomypancreatoduodenectomypostoperative pancreatic fistula

Outcome Measures

Primary Outcomes (1)

  • Incidence of pancreatic fistula ISGPF grade B or C

    Up to 90 days after surgery

Secondary Outcomes (1)

  • Incidence of postoperative complications, incidence of remnant pancreatitis

    Up to 90 days after surgery

Study Arms (2)

Group A: Modified Blumgart suture method (conventional treatment group)

PLACEBO COMPARATOR
Procedure: Modified Blumgart suture method

Group B: Three-sided mattress suture (test treatment group)

ACTIVE COMPARATOR
Procedure: Three-sided mattress suture

Interventions

During pancreaticoduodenectomy, the modified Blumgart suture method is used for pancreaticojejunostomy. For anastomosis, 5-0PDS is used for pancreatic duct mucosal anastomosis, and 3-0 or 4-0 monofilament non-absorbable suture is used for pancreaticojejunal mattress anastomosis.

Group A: Modified Blumgart suture method (conventional treatment group)

At the time of pancreaticoduodenectomy, the three-sided mattress suture is used as the pancreaticojejunostomy method. In addition to the conventional Blumgart modified suture, the three-sided mattress suture method adds a mattress anastomosis with 3-0 or 4-0 monofilament non-absorbable suture to the cranial and caudal sides of the pancreaticojejunostomy site.

Group B: Three-sided mattress suture (test treatment group)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for pancreaticoduodenectomy who have been determined to have a soft pancreas.
  • Preoperative CT images show that the pancreatic duct diameter at the planned site of pancreatic resection is 5mm or less.
  • ECOG Performance Status (PS) is 0-1.
  • Age 18 years or older.
  • Function of major organs (bone marrow, heart, liver, kidneys, lungs, etc.) is maintained.
  • Patients have sufficient judgment to understand the content of the research, and written consent has been obtained from the individual.

You may not qualify if:

  • Patients with severe ischemic heart disease
  • Patients with liver cirrhosis or active hepatitis
  • Patients with respiratory distress requiring oxygen due to interstitial pneumonia or pulmonary fibrosis
  • Patients undergoing dialysis due to chronic renal failure
  • Patients requiring combined resection of surrounding organs
  • Patients requiring arterial reconstruction of the superior mesenteric artery, common hepatic artery, celiac artery, etc.
  • Patients with active duplicate cancers that may affect adverse events or overall survival
  • Patients taking oral steroids for a long period that may affect adverse events
  • Patients with insufficient decision-making ability
  • Other subjects deemed inappropriate by the principal investigator or investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tokai University

Isehara-shi, Kanagawa, 259-1193, Japan

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Once PD is performed, there is no difference in postoperative radiographic findings between the two surgical approaches, so it should not affect the radiologist's assessment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 21, 2025

First Posted

March 4, 2025

Study Start

December 10, 2024

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

December 31, 2029

Last Updated

March 4, 2025

Record last verified: 2025-02

Locations